Sagimet Biosciences Inc. (SGMT) Earnings History
Annual and quarterly earnings data from 2019 to 2025
Loading earnings history...
SGMT EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
SGMT Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | 100.0% | -1537.0% | -1393.8% |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export SGMT earnings history in CSV or JSON format
Free sign-in required to download data
Sagimet Biosciences Inc. (SGMT) Earnings Overview
As of May 8, 2026, Sagimet Biosciences Inc. (SGMT) reported trailing twelve-month net income of -$51M, reflecting -9.0% year-over-year growth. The company earned $-1.58 per diluted share over the past four quarters.
Looking at the long-term picture, SGMT's historical earnings data spans multiple years. The company achieved its highest annual net income of -$11M in fiscal 2020.
Sagimet Biosciences Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including MDGL (-$309M net income, -30.1% margin), AKBA (-$21M net income, -2.3% margin), HALO ($317M net income, 22.7% margin), SGMT has comparable earnings metrics. Compare SGMT vs MDGL →
SGMT Earnings vs Peers
Earnings metrics vs comparable public companies
SGMT Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$51M | -12.0% | -$57M | $-1.58 | - | - |
| 2024 | -$46M | -63.5% | -$54M | $-1.45 | - | - |
| 2023 | -$28M | +8.6% | -$31M | $-1.53 | -1393.8% | -1537.0% |
| 2022 | -$30M | -24.8% | -$31M | $-1.38 | - | - |
| 2021 | -$24M | -115.0% | -$24M | $-1.10 | - | - |
| 2020 | -$11M | +20.3% | -$11M | $-0.51 | - | - |
| 2019 | -$14M | - | -$14M | $-0.64 | - | - |
See SGMT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SGMT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SGMT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSGMT — Frequently Asked Questions
Quick answers to the most common questions about buying SGMT stock.
Is SGMT growing earnings?
SGMT EPS fell to $-1.58, with earnings declining -9.0%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-51M.
What are SGMT's profit margins?
Sagimet Biosciences Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are SGMT's earnings?
SGMT earnings data spans 2019-2025. The declining earnings trend is -9.0% YoY. Historical data enables comparison across business cycles.